Last reviewed · How we verify
NVP-1203-R1 and NVP-1203-R2
NVP-1203-R1 and NVP-1203-R2 is a Small molecule drug developed by NVP Healthcare. It is currently in Phase 1 development. Also known as: NVP-1203-R1(A) and NVP-1203-R2(E).
At a glance
| Generic name | NVP-1203-R1 and NVP-1203-R2 |
|---|---|
| Also known as | NVP-1203-R1(A) and NVP-1203-R2(E) |
| Sponsor | NVP Healthcare |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- NVP-1203-R1 and NVP-1203-R2 CI brief — competitive landscape report
- NVP-1203-R1 and NVP-1203-R2 updates RSS · CI watch RSS
- NVP Healthcare portfolio CI
Frequently asked questions about NVP-1203-R1 and NVP-1203-R2
What is NVP-1203-R1 and NVP-1203-R2?
NVP-1203-R1 and NVP-1203-R2 is a Small molecule drug developed by NVP Healthcare.
Who makes NVP-1203-R1 and NVP-1203-R2?
NVP-1203-R1 and NVP-1203-R2 is developed by NVP Healthcare (see full NVP Healthcare pipeline at /company/nvp-healthcare).
Is NVP-1203-R1 and NVP-1203-R2 also known as anything else?
NVP-1203-R1 and NVP-1203-R2 is also known as NVP-1203-R1(A) and NVP-1203-R2(E).
What development phase is NVP-1203-R1 and NVP-1203-R2 in?
NVP-1203-R1 and NVP-1203-R2 is in Phase 1.
Related
- Manufacturer: NVP Healthcare — full pipeline
- Also known as: NVP-1203-R1(A) and NVP-1203-R2(E)
- Compare: NVP-1203-R1 and NVP-1203-R2 vs similar drugs
- Pricing: NVP-1203-R1 and NVP-1203-R2 cost, discount & access